Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage ...

In a regulatory filing, GMS disclosed that its CEO John Turner bought 3,650 shares of common stock on April 7th in a total transaction size of $255.5K. Discover outperforming stocks and invest ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Stay informed with the very latest news in motorcycling. Our crack team of reporters cover the issues you need to know about, from new bikes to community, and the latest tech to bike crime.

MASH is a severe form of nonalcoholic fatty liver disease where excess fat in the liver causes inflammation. About 5% of U.S. adults have MASH (short for metabolic dysfunction-associated ...

Bear witness to the fearsome and awe-inspiring monstrosities you will face in Monster Hunter Wilds with our comprehensive monster list ...

‘One of Dublin’s great sons’ – Eamon Farrell, father of Colin Farrell, remembered for ‘incredible’ generosity at funeral ...